Japan Ankylosing Spondylitis Drugs Market is expected to reach USD 480 million by 2032 | Major players - Novartis AG, Merck & Co., Inc, Amgen Inc, AbbVie Inc

Market Size and Growth:

The Global Ankylosing Spondylitis Drugs Market size reached USD 7.24 billion in 2022 and is expected to reach USD 13.32 billion by 2032, growing with a CAGR of 7% during the forecast period 2024-2032.

The Ankylosing Spondylitis Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/ankylosing-spondylitis-drugs-market?sz

The Ankylosing Spondylitis Drugs Market comprises pharmaceutical therapies used to manage ankylosing spondylitis, a chronic inflammatory disease affecting the spine and joints. It includes NSAIDs, biologics, TNF inhibitors, IL-17 inhibitors, and emerging targeted therapies, driven by rising disease awareness, early diagnosis, and advancements in immunology-based treatments worldwide.

Recent Key Developments of Japan:

✅ December 2025: Analysis highlighted growing AS prevalence and diagnostic rates in Japan, driving demand for biologics like TNF and IL-17 inhibitors amid improved awareness.

✅ November 2025: Real-world data confirmed ixekizumab's tolerability in Japanese patients, with common mild issues like infections and injection-site reactions, consistent with global trials.

✅ November 2025: Post-marketing study published on ixekizumab's long-term safety and effectiveness in Japanese AS and non-radiographic axial spondyloarthritis patients, showing no serious adverse events and physician-rated improvement in over 75% of cases over 96 weeks.

Recent Key Developments of Europe:

✅ December 2025: EULAR updates focused on axial spondyloarthritis management, though not AS-specific, signaling ongoing guideline refinements for IL-17 inhibitors in Europe.

✅ December 2025: Market report emphasized investment in novel biologics for AS treatment drugs, noting TNF inhibitors' 45% share and trends toward biosimilars for cost-effective access.

✅ October 2025: Telerehabilitation efficacy case report for AS patients underscored complementary non-drug innovations, potentially influencing drug-combination strategies in European care.

List of the Key Players in the Ankylosing Spondylitis Drugs Market:

Novartis AG
Merck & Co., Inc
Regeneron Pharmaceuticals, Inc
Amgen Inc
AbbVie Inc
Eli Lilly and Company
UCB, S.A
Johnson & Johnson Services, Inc
Bristol-Myers Squibb Company
Pfizer Inc

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/ankylosing-spondylitis-drugs-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Ankylosing Spondylitis Drugs Market:

By Drug Class: Tumor necrosis factor (TNF) blocker, Non-steroidal anti-inflammatory drugs, Disease-modifying antirheumatic drugs, Interleukin-17 (IL-17) inhibitor, Others.

By Route of Administration: Parenteral, Oral.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=ankylosing-spondylitis-drugs-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Ankylosing Spondylitis Drugs market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Ankylosing Spondylitis Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Ankylosing Spondylitis Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Ankylosing Spondylitis Drugs Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:
◆ How big is the Ankylosing Spondylitis Drugs Market in 2025?
◆ What is the projected growth rate of the Ankylosing Spondylitis Drugs Market through 2033?
◆ Who are the key players in the Ankylosing Spondylitis Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.